Segment Information (Tables)

6 Months Ended

Dec. 28, 2013

Segment Information [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Consumer Healthcare		Nutritionals		Rx Pharma-ceuticals		API		Specialty Sciences(1)			Other		Unallocated expenses			Total(2)
Second Fiscal Quarter 2014
Net sales	$	536.3	$	139.7	$	246.6	$	30.0	$	7.4		$	19.0	$	—		$	979.0
Operating income      (loss)	$	89.5	$	13.3	$	100.4	$	8.2	$	(19.0	)	$	0.6	$	(106.4	)	$	86.6
Amortization of intangibles	$	5.3	$	7.4	$	21.5	$	0.5	$	8.7		$	0.4	$	—		$	43.8
Total assets	$	2,345.5	$	1,014.0	$	1,940.1	$	284.7	$	8,023.8		$	104.7	$	—		$	13,712.8
Second Fiscal Quarter 2013
Net sales	$	539.3	$	121.9	$	162.5	$	40.9	$	—		$	18.4	$	—		$	883.0
Operating income      (loss)	$	86.1	$	7.2	$	64.1	$	13.8	$	—		$	0.7	$	(8.0	)	$	163.9
Amortization of intangibles	$	4.9	$	7.3	$	8.5	$	0.5	$	—		$	0.4	$	—		$	21.6
Total assets	$	1,771.5	$	960.7	$	1,184.9	$	275.4	$	—		$	101.9	$	—		$	4,294.4

	Consumer Healthcare		Nutritionals		Rx Pharma-ceuticals		API		Specialty Sciences(1)			Other		Unallocated expenses			Total(2)
Year-to-Date Fiscal 2014
Net sales	$	1,074.8	$	268.7	$	450.2	$	73.2	$	7.4		$	38.1	$	—		$	1,912.4
Operating income      (loss)	$	179.5	$	21.0	$	183.5	$	30.6	$	(19.0	)	$	1.8	$	(131.2	)	$	266.2
Amortization of intangibles	$	10.6	$	14.7	$	37.7	$	1.0	$	8.7		$	0.9	$	—		$	73.6
Year-to-Date Fiscal 2013
Net sales	$	989.7	$	225.3	$	325.5	$	77.3	$	—		$	34.9	$	—		$	1,652.7
Operating income      (loss)	$	165.4	$	11.0	$	132.6	$	27.1	$	—		$	1.1	$	(16.8	)	$	320.4
Amortization of intangibles	$	7.1	$	14.6	$	16.9	$	0.9	$	—		$	0.8	$	—		$	40.3

⁽¹⁾    Specialty Sciences only includes activity from December 18, 2013 to December 28, 2013.

⁽²⁾Amounts may not cross-foot due to rounding.